Skip to main content

Live Xenetic Biosciences, Inc. Share Price Chart

O H L

Xenetic Biosciences, Inc. Performance Overview

Days Range
▼
$2.22Low
$2.30High

Markets Today

Previous Close$2.24
Open$2.30
Volume43,198
Day's Range$2.22 - $2.30
52W Range$1.87 - $13.93
Market Cap$5.25 M

Historical Performance

1M Returns-51.62
3M Returns-19.13
6M Returns-25.58
1Y Returns-31.29
5Y Returns-87.83
10Y ReturnsNA

Xenetic Biosciences, Inc. Fundamentals

Market Cap$5.25 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.40
EPS TTM$-1.20
Quarterly Earnings Growth YOYN/A
PB Ratio0.86
EBITDA$-5.81 M
Profit MarginN/A
Market Cap$5.25 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.40
EPS TTM$-1.20
Quarterly Earnings Growth YOYN/A
PB Ratio0.86
EBITDA$-5.81 M
Profit MarginN/A

Xenetic Biosciences, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$593.26 K$589.90 K$0$0$806.92 K$660.60 K
Gross Profit +$593.26 K$589.90 K$0$0$806.92 K$660.60 K
Operating Income -$942.41 K-$724.41 K-$1.57 M-$1.39 M-$502.12 K-$971.69 K
EBITDA -$942.41 K-$724.41 K-$1.57 M-$1.39 M-$502.12 K-$971.69 K
Interest Expense $0$0$30.78 K-$104.20 K$0$0
Depreciation $0$0$0$0$0$0
Income Before Tax -$903.14 K-$688.70 K-$509.94 K-$579.08 K-$456.38 K-$929.70 K
Income Tax Expense $0$0$0$0$0$0
Net Income +-$903.14 K-$688.70 K-$509.94 K-$579.08 K-$456.38 K-$929.70 K
Net Profit Margin -152.23%-116.75%---56.56%-140.73%

Xenetic Biosciences, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.54 K$1.54 K$1.54 K$2.29 K$2.29 K$2.35 K
Reserve & Surplus -$197.84 M-$198.53 M-$199.04 M-$199.62 M-$200.08 M-$201.01 M
Non-Current Liabilities $0$0$0$0$0$0
Current Liabilities $667.93 K$903.43 K$1.11 M$968.02 K$958.24 K$894.98 K
Total Liabilities $667.93 K$903.43 K$1.11 M$968.02 K$958.24 K$894.98 K
Fixed Assets $0$0$0$0$0$0
Current Assets $5.48 M$5.35 M$5.07 M$8.05 M$7.60 M$6.65 M
Total Assets $5.79 M$5.35 M$5.07 M$8.36 M$7.91 M$6.97 M

Xenetic Biosciences, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$903.14 K-$688.70 K-$509.94 K-$579.08 K-$456.38 K-$929.70 K
Operating Cash Flow -$1.00 M-$383.83 K-$658.25 K-$242.68 K-$536.38 K-$875.49 K
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $0$0$0$4.00 M$0$0
Change in Cash -$1.00 M-$383.83 K-$658.25 K$3.76 M-$536.38 K-$875.49 K

Xenetic Biosciences, Inc. Return Calculator

The Xenetic Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,087
Invested Amount$10,000
Est. Returns$-8,913
Invest in USA Stock Today

About Xenetic Biosciences, Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

FAQs

Xenetic Biosciences, Inc. (XBIO) share price as of October 3, 2026 is $2.00. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Xenetic Biosciences, Inc. (XBIO) Share by opening an international trading account with Angel One.
Purchasing Xenetic Biosciences, Inc. (XBIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Xenetic Biosciences, Inc. (XBIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Xenetic Biosciences, Inc. (XBIO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Xenetic Biosciences, Inc. on October 3, 2026, is $5.25 M.
Xenetic Biosciences, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Xenetic Biosciences, Inc. (XBIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL